XML 23 R43.htm IDEA: XBRL DOCUMENT v3.3.0.814
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 24, 2012
Sep. 28, 2011
Mar. 24, 2010
May. 31, 2014
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Aug. 01, 2015
Jun. 30, 2015
Dec. 31, 2014
Related-Party Transactions (Textual) [Abstract]                      
Long-term other assets         $ 597,570   $ 597,570       $ 474,568
Subsidiary ownership percentage by parent       85.00%           91.00%  
Receivable from sale of intangible assets       $ 1,000,000              
Future payments to be received from sale of intangible assets       $ 1,000,000              
Equity ownership percentage after transaction       20.00%              
Maximum amount of additional equity fundraising       $ 10,000,000              
Ownership of investment         16.90%   16.90%        
Carrying value of investment       $ 0 $ 7,100,000   $ 7,100,000        
Available-for-sale Securities                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (shares)         395,758   395,758        
Available-for-sale Securities | VGX International [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (shares)                 465,364    
GeneOne Life Sciences [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Payment received for license granted     $ 3,000,000                
Deferred revenue from affiliated entity     $ 3,000,000                
Period over which deferred revenue from affiliated entity will be recognized in years     8 years                
Revenue from related parties         $ 113,000 $ 113,000 $ 338,000 $ 367,000      
Operating expenses related to affiliated entity         1,100,000 $ 400,000 6,500,000 $ 4,100,000      
Accounts receivable balance         0   0       2,000
Accounts payable and accrued liability         2,800,000   2,800,000       28,000
Long-term other assets         $ 213,000   $ 213,000       $ 260,000
OncoSec [Member] | First warrant [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Common stock purchase warrant (in shares)   50,000                  
Term of the warrants in years   5 years                  
Exercise price of a five-year warrant ($ per share)   $ 24.00                  
OncoSec [Member] | Second warrant [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Common stock purchase warrant (in shares) 150,000                    
Term of the warrants in years 5 years                    
Exercise price of a five-year warrant ($ per share) $ 20.00